Subscribe to receive the conference news and updates  

Symposia

Home  Program Symposia

Symposia & Oral Sessions

  • ALL
  • Awards Session
  • Biofabrication
  • Biomaterials
  • Bone and dental biology
  • Cardiovascular
  • Enabling Technology
  • Exosomes
  • FTERM Session
  • Immune Engineering
  • Joint Sesion
  • KWSE Session
  • Manufacturing & Bioprocess
  • Musculoskeletal
  • Neurobiology
  • Obstetrics and Gynecology
  • Organoids
  • Otorhinolaryngology
  • Plastic surgery
  • Plenary Lecture
  • Pre-conference
  • Stem Cells
  • SYIS
  • Tissue Engineering
  • Session Topic
    Pre-conference
    Session Title
    The 2nd Advanced Regenerative Medicine Forum 2022
    Date & Time
    2022-10-05 09:30~12:00
    Room
    Halla Hall
    Chair
    RMAF (RMAF, Korea, Republic of)
    Plenary Speaker
    MOHW (MOHW, Korea, Republic of)
    Speaker
    Masayuki Nomura (FIRM/ Asahi Kasei Corporation, Japan)
    James J. Yoo (Wake Forest Institute for Regenerative Medicine, USA)
    Francesca Lorraine Lim (Singapore General Hospital, Singapore)

    Description

  • Session Topic
    Plenary Lecture
    Session Title
    PL1_Plenary Lecture 1
    Date & Time
    2022-10-05 13:30~14:30
    Room
    Tamna Hall
    Chair
    Il Woo Lee (Catholic University of Korea, Korea, Republic of)
    Plenary Speaker
    James J. Yoo (Wake Forest Institute for Regenerative Medicine, USA)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S1-A_Biofabrication for tissue engineering and personalized disease models
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Halla Hall
    Chair
    Kris Kilian (University of New South Wales, Australia)
    Junmin Lee (Pohang University of Science and Technology (POSTECH), Korea, Republic of)
    Keynote
    Eben Alsberg (University of Illinois at Chicago, USA)
    Speaker
    Su Ryon Shin (Harvard Medical School/Brigham and Women’s Hospital, USA)
    Jeroen Leijten (University Twente, Netherlands)
    Stephanie Seidlits (University of Texas at Austin, USA)
    Oju Jeon (University of Illinois Chicago, USA)
    (

    Description

    Tissue engineering is an interdisciplinary field aimed at maintaining, restoring, and promoting the normal function of organs and tissues using biomaterials and live cells by incorporating concepts from materials science, bioengineering, biological sciences, and medicine. Biofabrication aims to produce engineered tissue constructs to repair or replace damaged or diseased human tissues with full functionalities. In this regard, the biofabrication of multifunctional and bioactive biomaterials that can replace the cellular/tissue microenvironment is critical for personalized tissue regeneration and disease modeling. This symposium will highlight recent trends in the development of biomaterials-based biofabrication strategies that play functional roles in regulating cellular behaviors and tissue regeneration. Moreover, the session will also feature frontier 3D bioprinting and stimuli-responsive materials for design of complex microenvironments, and translational strategies for taking these approaches from ‘Bench to Bedside’ for personalized disease modeling and regenerative therapies. We anticipate that our interdisciplinary session including biofabrication, tissue engineering, biomaterials, and regenerative medicine will be of great significance to scientists and engineers working in life sciences, biomedical engineering and clinical medicine.

  • Session Topic
    Cardiovascular
    Session Title
    S1-B_Clinical application of therapeutics for cardiac repair
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Samda Hall
    Chair
    Hun-Jun Park (The Catholic University of Korea, Seoul St. Mary's Hospital, Korea, Republic of)
    Suk Ho Bhang (Sungkyunkwan University, Korea, Republic of)
    Keynote
    Hun-Jun Park (The Catholic University of Korea, Korea, Republic of)
    Speaker
    Paulo André Nóbrega Marinho (T&R Biofab, Korea, Republic of)
    Suk Ho Bhang (Sungkyunkwan University, Korea, Republic of)
    Yoonhee Jin (Yonsei University Medical College, Korea, Republic of)
    Muhammad Shafiq (Department of Chemical Engineering, Faculty of Engineering, Graduate School, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka, Japan, Japan)

    Description

    Ischemic heart disease is a leading cause of death worldwide. Injury to the heart is followed by loss of the damaged cardiomyocytes, which are replaced with fibrotic scar tissue. Depletion of cardiomyocytes results in decreased cardiac contraction, which leads to pathological cardiac dilatation, additional cardiomyocyte loss, and mechanical dysfunction, culminating in heart failure. Many therapies have focused on preventing the progressive process of heart failure including cellular and noncellular therapies. In this session, we introduce novel therapeutic approaches using cardiac organoid/spheroids and biomaterials for in-situ cardiac regeneration, which offering the potential to control cardiac remodelling and redirect the adult heart to a regenerative state.

  • Session Topic
    Plastic surgery
    Session Title
    S1-C_Tissue engineering for plastic surgery
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Room 301
    Organizer
    Ji-Ung Park (Seoul National University Boramae Medical Center, Korea, Republic of)
    Chair
    Jong Won Rhie (Catholic University of Korea, College of Mdicine, Korea, Republic of)
    Chan Yeong Heo (Seoul National University Bundang Hospital, Korea, Republic of)
    Keynote
    Sang Jin Lee (Wake Forest University School of Medicine, USA)
    Speaker
    Suk-Ho Moon (The Catholic University of Korea, Korea, Republic of)
    Chul Ho Jang (Chonnam National University, Korea, Republic of)
    Yuna Kuriki (Graduate School of Life and Medical Sciences, Doshisha University, Japan)
    Sung-hwan Yoon (Department of Plastic and Reconstructive Surgery, SMG-SNU Boramae Medical Center, Korea, Republic of)

    Description

  • Session Topic
    Exosomes
    Session Title
    S1-D_Extracellular vesicles as novel therapeutics
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Room 302
    Chair
    Yong Woo Cho (Hanyang University ERICA, ExoStemTech Inc., Korea, Republic of)
    Dong-Gyu Jo (School of Pharmacy, Sungkyunkwan University, Korea, Republic of)
    Keynote
    Yun Sil Chang (Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea, Republic of)
    Speaker
    Han Young Kim (Catholic University of Korea, Korea, Republic of)
    Hark Kyun Kim (Sungkyunkwan University, Korea, Republic of)
    Catherine Le Visage (Inserm, Nantes Universite, France)
    Yong Woo Cho (Hanyang University ERICA, Korea, Republic of)

    Description

  • Session Topic
    Biofabrication
    Session Title
    S1-E_Biomimetic scaffolds for neural tissue regeneration
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Room 303
    Chair
    Sing Yian Chew (Nanyang Technological University, Singapore)
    Ying-Chieh Chen (National Tsing-Hua University, Chinese Taipei)
    Keynote
    Jianwu Dai (Center for Regenerative Medicine, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, China)
    Speaker
    Ying-Chieh Chen (National Tsing-Hua University, Chinese Taipei)
    Christy Kwokdinata (School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore)
    Elizabeth Zoneff (University of Melbourne, Australia)
    Jeong-Won Choi (Ulsan National Institute of Science and Technology, Korea, Republic of)

    Description

    Regeneration of neural tissues, especially that of the central nervous system, is a significant challenge in regenerative medicine. In addition to neurons, glial cells, such as astrocytes and oligodendrocytes, also play significant roles in determining regeneration and functional outcomes. Hence, the ability to specifical-ly direct the behavior of neural cells is of therapeutic importance and relevance. Extracellular signaling plays critical roles in dictating cell fate. Besides biochemical signals from drugs, growth factors and nu-cleic acids, physical signals like matrix topography and compliance also affect cell response. This sympo-sium gathers the recent advancements in neural differentiation/transdifferentiation and/or bio-functional scaffold designs for neural tissue engineering applications.

  • Session Topic
    SYIS
    Session Title
    S1-F_SYIS_Tissue regeneration
    Date & Time
    2022-10-05 14:30~16:00
    Room
    Room 401
    Chair
    Hwan Kim (Korea National University of Transportation, Korea, Republic of)
    Tsuyoshi Kimura (Tokyo Medical and Dental University, Japan)
    Speaker
    Mako Kobayashi (Tokyo Medical and Dental University, Japan)
    Cininta Savitri (Korea Institute of Science and Technology, Korea, Republic of)
    Bhavana Nayer (Australian Regenerative Medicine Institute, Monash University, Australia)
    Shih-Yen Wei (National Tsing-Hua University, Chinese Taipei)
    Sujin Noh (Department of Biomedical Sciences, Graduate School of Ajou University, Korea, Republic of)
    Jae Seo Lee (Department of Dentistry, Graduate School, Kyung Hee University, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Korea, Republic of)
    Juyeon Kim (Sungkyunkwan University, Korea, Republic of)
    Seungyeun Cho (POSTECH, Korea, Republic of)
    Chengchong Ai (National University of Singapore, Singapore)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S2-A_Biomaterials and enabling technologies innovation for food sustainability and security
    Date & Time
    2022-10-05 16:30~18:00
    Room
    Halla Hall
    Chair
    Lay Poh Tan (Nanyang Technological University, Singapore)
    Tatsuya Shimizu (Tokyo Women's Medical University, Japan)
    Keynote
    Ai Shima (The University of Tokyo, Japan)
    Speaker
    Hironobu Takahashi (Tokyo Women's Medical University, Japan)
    Kee Woei Ng (Nanyang Technological University, Singapore)
    Katsuhisa Sakaguchi (Waseda University, Japan)
    Rakesh Bhaskar (Yeungnam University, Korea, Republic of)

    Description

  • Session Topic
    Plastic surgery
    Session Title
    S2-C_Advances in Wound Healing and Scar Therapy
    Date & Time
    2022-10-05 16:30~18:00
    Room
    Room 301
    Chair
    Ji-Ung Park (Seoul National University Boramae Medical Center, Korea, Republic of)
    Su Ryon Shin (Harvard Medical School/Brigham and Women’s Hospital, USA)
    Keynote
    Su Ryon Shin (Harvard Medical School/Brigham and Women’s Hospital, USA)
    Speaker
    Su-Jin Heo (University of Pennsylvania, USA)
    Le Quang Bach (Bioprocessing Technology Institute, Singapore)
    Jiranuwat Sapudom (Laboratory for Immuno Bioengineering Research and Applications, Division of Engineering, New York University Abu Dhabi, Abu Dhabi, UAE, United Arab Emirates)
    Wooyeol Baek (Yonsei University, Korea, Republic of)

    Description

    In order to repair damaged tissue, it is important to maintain balance and homeostasis. However, the incidence of difficult-to-heal chronic wounds due to diabetic foot, arteriovenous ulcer, burn, pressure sore, etc. is rapidly increasing worldwide. Recently, various wound healing technologies including electrical stimulation, nano-complex material, natural and synthetic dressing materials and so on have been developed to overcome these problematic chronic wounds. In addition, hypertrophic scars or keloids appearing after wound healing is another important issue which can have serious clinical deformity. Studies for overcoming these scars and achieving scarless wound healing are being actively conducted. This session is intended to introduce the latest research on wound healing acceleration and avoiding scars.

  • Session Topic
    Exosomes
    Session Title
    S2-D_The emerging theragnostic role of extracellular vesicles
    Date & Time
    2022-10-05 16:30~18:00
    Room
    Room 302
    Chair
    Joy Wolfram (University of Queensland, Australia)
    Jung Seung Lee (Sungkyunkwan University, Korea, Republic of)
    Keynote
    Michael Davis (Emory University, USA)
    Speaker
    Giorgia Pastorin (National University of Singapore, Singapore)
    Joy Wolfram (The University of Queensland, Australia)
    Sun Hwa Kim (Korea Institute of Science and Technology, Korea, Republic of)
    A-Ryeong Gwon (Exostemtech Co., Ltd,, Korea, Republic of)

    Description

    Extracellular vesicles are key mediators of intercellular transfer of bioactive molecules, and have promising potential as biotherapeutics and diagnostics. This symposium will highlight opportunities and challenges for extracellular vesicle therapeutics and diagnostics in regenerative science and medicine. Key topics include isolation, scale up, characterization, storage, engineering, drug delivery, and disease-specific applications of extracellular vesicle treatment and diagnostic strategies. Speakers include leaders in the field of extracellular vesicles from industry and academia.

  • Session Topic
    Biofabrication
    Session Title
    S2-E_Vasculogenesis and angiogenesis for functional tissue engineering
    Date & Time
    2022-10-05 16:30~18:00
    Room
    Room 303
    Chair
    Xuebin Yang (University of Leeds, United Kingdom)
    Michiya Matsusaki (Osaka University, Japan)
    Keynote
    Xuebin Yang (University of Leeds, United Kingdom)
    Michiya Matsusaki (Osaka University, Japan)
    Speaker
    In Kyong Shim (Asan Medical Center, Korea, Republic of)
    Hidekazu Sekine (Tokyo Women's Medical University, Japan)

    Description

    The ability to vascularize engineered tissues is currently one of the greatest hurdles in tissue engineering. Therefore, the research on vasculogenesis in vitro and angiogenesis in vivo are crucial for the generation of large-scale functional tissues for clinical transplantation. This will ensure the surgical integration of the engineered tissues into the patient’s own vasculature after implantation and to increase the success rate for clinical translation.
    This symposium will invite experts to give keynote and invited lectures on: 1) the importance of vasculogenesis and angiogenesis on functional tissue engineering; 2) current advance in using stem cells and in vitro model for enhancing vasculagenesis; 3) in vivo models for promoting angiogenesis of tissue engineering constructs. We will also select the best abstracts submitted to this symposium for oral presentations. This symposium will add educational value for junior faculties and early career researchers to learn the importance of vasculogenesis and angiogenesis on functional tissue engineering and provide the opportunity for exchange knowledge and skill in this topic, which has great impact for translational research in regenerative medicine.
    Dr Yang (University of Leeds, UK) has both clinical background in orthopaedics and expertise on stem cell therapy and tissue engineering using in vitro and in vivo models. Dr Matsusaki (University of Osaka, Japan) is an expert on functional biomaterials for tissue engineering applications. His group has developed novel 3D in vitro models for inducing blood capillary, constructing vascularized hepatic tissue and controlling of vascular network.
    Dr Yang has successfully organized/chaired several symposia on osteocondral/bone tissue engineering, animal models and clinical translation topics for TERMIS-WCs 2012/2015/2021, TERMIS-AP 2013/2014/2016/2017, and TERMIS EU 2019. Both the chair and co-chair will use social media and professional societies’ mailing list(s) to encourage more people to submit high quality abstracts to this symposium.

  • Session Topic
    SYIS
    Session Title
    S2-F_SYIS_Biomaterials
    Date & Time
    2022-10-05 16:30~18:00
    Room
    Room 401
    Chair
    Hee Ho Park (Hanyang University, Korea, Republic of)
    Yunji Lee (POSTECH(Pohang university of science and technology), Korea, Republic of)
    Speaker
    Yi Sun Choi (Yonsei University, Korea, Republic of)
    Tsung-Yun Wu (National Taiwan University of Science and Technology, Chinese Taipei)
    Huajian Chen (Research Center for Functional Materials, National Institute for Materials Science; Sch. of Pure and Applied Science, University of Tsukuba, Japan)
    Jiyu Hyun (Sungkyunkwan University, Korea, Republic of)
    Fiona Verisqa (Division of Biomaterials and Tissue Engineering, Eastman Dental Institute, University College London, Royal Free Hospital, Pond Street, London, NW3 2QG, UK, United Kingdom)
    Yunji Lee (POSTECH(Pohang university of science and technology), Korea, Republic of)
    Jinyoung Yun (POSTECH, Korea, Republic of)
    Marcus Ground (University of Otago, New Zealand)
    Elmira Mohamed (Australian National University, Australia)

    Description

  • Session Topic
    Cardiovascular
    Session Title
    S2-B_Recent advances in myocardial tissue engineering
    Date & Time
    2022-10-05 16:30~18:10
    Room
    Samda Hall
    Organizer
    Tatsuya Shimizu (Tokyo Women's Medical University, Japan)
    Chair
    Katsuhisa Matsuura (Tokyo Women's Medical University, Japan)
    Keynote
    Anthony (Tony) Weiss (University of Sydney, Australia)
    Speaker
    Katsuhisa Matsuura (Tokyo Women's Medical University, Japan)
    Aswathi Gopalakrishnan (Australian Institute for Bioengineering and Nanotechnology, School of Chemical Engineering,The University of Queensland, Australia)
    Yongjun Jang (Korea University, Korea, Republic of)
    Hazal Gezmis (University of Oxford, United Kingdom)
    Linyang Liu (the University of Sydney, Australia)

    Description

    Myocardial tissue engineering has been pursued for the last 20 years. Cell injection and cell sheet transplantation have been already clinically applied in the word, however their effects have been limited. It is because main mechanism in those therapy mainly depends on paracrine effects originated from transplanted cells. Mixture of several cytokines improve damaged hear function via neovascularization, inhibition of cell death and fibrosis. Therefore, the shortage of cardiomyocytes has not been fundamentally resolved. Recent development of human iPS cell-derived cardiomyocytes has opened new possibilities that transplanted cells might directly support the heart function. Human iPS cell-derived cardiomyocyte sheet transplantation has been just started clinically in Japan. Furthermore, functionally beating human myocardial tissues have been successfully engineered using iPS cell-derived cardiomyocytes. Mass production and maturation of these cells have been pursued and in vitro neovascularization is one of the most critical challenges for fabricating thick myocardial tissue graft which can support heart function and improving cardiac output by their-own contraction. In this symposium, recent advances in myocardial tissue engineering using human cardiomyocytes will be presented and discussed.

  • Session Topic
    Plenary Lecture
    Session Title
    PL2_Plenary Lecture 2
    Date & Time
    2022-10-06 09:00~10:00
    Room
    Halla Hall
    Chair
    Rui L. Reis (University of Minho/3B's Research Group, Portugal)
    Plenary Speaker
    Hsing Wen Sung (Department of Chemical Engineering, National Tsing Hua University, Hsinchu, Taiwan (ROC), Chinese Taipei)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S3-A_Directing cell/tissue fate by extracellular signaling
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Halla Hall
    Chair
    Sing Yian Chew (Nanyang Technological University, Singapore)
    Hyuk Sang Yoo (Kangwon National University, Korea, Republic of)
    Keynote
    William Wagner (University of Pittsburgh, McGowan Institute for Regenerative Medicine, USA)
    Catherine Le Visage (Inserm, Nantes Université, France)
    Speaker
    Hyuk Sang Yoo (Kangwon National University, Korea, Republic of)
    Kang Lin (The University of New South Wales, Australia)

    Description

    Extracellular signaling plays significant roles in dictating cell fate. In particular, physical signals like ma-trix topography and compliance affect cellular response. In combination with extracellular biochemical signals from drugs, growth factors and nucleic acids, synergistic effects are often seen. This symposium gathers the recent advancements in bio-functional scaffold designs that focus on imparting synergistic physical and biochemical cues to direct cellular differentiation and tissue regeneration for regenerative medicine.

  • Session Topic
    Otorhinolaryngology
    Session Title
    S3-B_Stem cell and regenerative medicine in head and neck surgery
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Samda Hall
    Chair
    Han Su Kim (Ewha Womans University, Korea, Republic of)
    Inho Jo (Korean Fund for Regenerative Medicine, Korea, Republic of)
    Keynote
    Han Su Kim (Ewha Womans University College of Medicine, Korea, Republic of)
    Speaker
    Sang Jin Lee (Wake Forest University School of Medicine, USA)
    Byungjoo Lee (Pusan National University Hospital, Korea, Republic of)
    Seong Keun Kwon (Seoul National University Hospital, Korea, Republic of)
    Yo Kishimoto (Kyoto University, Japan)

    Description

    In this current session, we aim to discuss cell-based tissue engineering technologies in the field of head and neck surgery, particularly focus on airway regeneration

  • Session Topic
    Bone and dental biology
    Session Title
    S3-C_Various tissue engineered regeneration in oral and maxillofacial region
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Room 301
    Organizer
    June-Ho Byun (Gyeongsang National University College of Medicine, Korea, Republic of)
    Chair
    Seong Ho Choi (Yonsei University, Korea, Republic of)
    Bu-Kyu Lee (Asan Medical Center, Korea, Republic of)
    Keynote
    Takuya Matsumoto (Okayama University, Japan)
    Speaker
    Jun-Beom Park (Department of Periodontics, College of Medicine, The Catholic University of Korea, Korea, Republic of)
    Dae-Seok Hwang (Department of Oral and Maxillofacial Surgery, Dental School, Pusan National University, Korea, Republic of)
    Hoon Joo Yang (Seoul National University Dental Hospital, Korea, Republic of)
    Jae Kook Cha (Yonsei University, Korea, Republic of)

    Description

    Recently, substantial progress has been reported for tissue-engineered bone formation and its use to repair bone defects. Ideal strategies for tissue-engineered bone formation utilize optimal combinations of biodegradable three-dimensional porous scaffolds that closely mimic the natural bone extracellular matrix niche, osteoprogenitor cells that synthesize the bone tissue matrix, and biologically active growth factors that induce or promote endogenous bone and vascular formation. However, many specific procedures for the preparation of appropriate cells or biomaterials for use in therapy are still needed. The main aims in this session are to discuss cell-based or biomaterial-based tissue engineered regeneration for the reconstruction of various defects in oral and maxilofacial region, including bone and nerve.

  • Session Topic
    Joint Sesion
    Session Title
    S3-D_KSGCT joint session
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Room 302
    Chair
    Suk Ho Bhang (Sungkyunkwan University, Korea, Republic of)
    Seokjoong Kim (ToolGen, Korea, Republic of)
    Keynote
    Dae-Won Kim (Yonsei University, Korea, Republic of)
    Speaker
    Seokjoong Kim (ToolGen, Korea, Republic of)
    Kwang-il Lim (Sookmyung Women's University, Korea, Republic of)
    Kyoung-Sik Moon (Korea Institute of Toxicology, Korea, Republic of)
    Jeong Man An (Hanyang University, Korea, Republic of)

    Description

  • Session Topic
    Biofabrication
    Session Title
    S3-E_Biofabrication of multicellular engineered living systems
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Room 303
    Chair
    Hyunjoon Kong (University of Illinois at Urbana-Champaign, USA)
    Hojeong Jeon (Korea Institute of Science and Technology, Korea, Republic of)
    Keynote
    M Taher A Saif (University of Illinois at Urbana-Champaign, USA)
    Speaker
    Eben Alsberg (University of Illinois at Chicago, USA)
    Sung Gap Im (KAIST, Korea, Republic of)
    Hojeong Jeon (Korea Institute of Science and Technology, Korea, Republic of)
    Hyunjoon Kong (University of Illinois at Urbana-Champaign, USA)

    Description

    In biosystems, cells perform their intended functions collectively by forming three-dimensional structures to evolve over time. These structures are composed of cells that operate complex physiological activities throughout active or passive cell-cell and cell-matrix interactions. Extensive research has focused on individual cells' genotypic and phenotypic activities in controlled environments engineered with biomaterials and fabrication technologies. In contrast, little is known about the extent to which cellular adhesion to neighboring cells in the 3D clusters modulates the complex morphogenesis and physiological function of engineered tissue and organs and underlying fundamental process. Such a knowledge gap has been one of the challenges towards successful tissue and organ regeneration.

    We, therefore, propose a symposium that can address this grand challenge of measuring and regulating multi-cellular systems, including organoids and biological machines, that exhibit desired functionalities and perform prescribed tasks. These multicellular systems can perform sensing, information processing, actuation, protein secretion, and transport elements. We plan to invite leaders in this biophysics and fabrication field and learn how multiple cells interact to integrate their internal developmental program, determine their phenotypes, and build biosystems with physiological or pathophysiological activities. Throughout this symposium, the audience will be able to advance a fundamental understanding of cell-cell interactions and their control by biochemical and mechanical cues and understand how to predict and engineer physiologically functional tissues and organs. Therefore, this symposium will define the disciplines crucial for building new tissue and organs for a wide range of applications. Furthermore, we can construct complex systems to perform new tasks that have never been explored before.

  • Session Topic
    SYIS
    Session Title
    S3-F_SYIS_Delivery systems
    Date & Time
    2022-10-06 10:30~12:00
    Room
    Room 401
    Chair
    Hee-Gyeong Yi (Chonnam National University, Korea, Republic of)
    Pei Leng Tan (School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore., Singapore)
    Speaker
    Pei Leng Tan (School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore., Singapore)
    Sang Hoon Jeong (Pohang University of Science and Technology, Korea, Republic of)
    Shou Jin Phang (Department of Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia)
    Hee Su Sohn (Seoul National University, Korea, Republic of)
    Kazuki Moroishi (Osaka university, Japan)
    Yi-Kai Chen (Department of Pharmacology, Monash University, Australia)
    Kiyoon Min (Gwangju Institute of Science and Technology, Korea, Republic of)
    Shiva Soltani Dehnavi (ACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, ANU College of Health & Medicine, Australia. College of Engineering and Computer Science, School of Engineering, Australia, Australia)
    Se Hun Chung (University College London, United Kingdom)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S4-A_Translational regenerative medicine: bench to bedside applications
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Halla Hall
    Chair
    Sang Jin Lee (Wake Forest School of Medicine, USA)
    Sang Hyug Park (Pukyong National University, Korea, Republic of)
    Keynote
    Makoto Komura (The University of Tokyo, Japan)
    Deok-Ho Kim (Johns Hopkins University, USA)
    Geun Hyung Kim (Sungkyunkwan University, Korea, Republic of)
    Hong Kyun Kim (School of Medicine, Kyungpook National University, Korea, Republic of)
    Hak Soo Choi (Harvard Medical School, USA)

    Description

    This special session will report state-of-the-art tissue engineering and regenerative medicine applications by addressing science, engineering, development, regulatory, biomanufacturing, and clinical aspects of the field. This session will explore the translation and practical use of biofabrication, tissue engineering, and regenerative medicine strategies. The session will invite six keynote speakers who have extensive translational research expertise and experience.

    Generally, TERMIS attendees who are involved in biomedical engineering, cell biology, molecular biology, and material science may well be interested in this topic, as all of these disciplines are required for the development of translational regenerative medicine products and biomanufacturing.

  • Session Topic
    Otorhinolaryngology
    Session Title
    S4-B_Up-to-date technology for tissue engineering in otorhinolaryngology: a biofabrication perspective
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Samda Hall
    Chair
    Byungjoo Lee (Pusan National University Hospital, Korea, Republic of)
    Haesang Park (Hallym University, College of Medicine, Korea, Republic of)
    Keynote
    Chan Hum Park (Hallym University, Nanobio Regenerative Medical Institute, Korea, Republic of)
    Speaker
    Kyu Young Choi (Hallym University, Korea, Republic of)
    Minbo Shim (Cheong Min Clinic, Korea, Republic of)
    Claudio Ricci (University of Pisa, Dept. of Civil and Industrial Engineering, Italy)
    Celine Abueva (Dankook Institute of Medicine and Optics, Dankook University, Cheonan, Korea, Republic of)

    Description

    In this session, we aim to discuss up-to-date technologies for tissue engineering in the field of ENT, particularly biofabrication perspective.

  • Session Topic
    Bone and dental biology
    Session Title
    S4-C_Regenerative dentistry
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Room 301
    Chair
    Joo-Cheol Park (Seoul National University, Korea, Republic of)
    June-Ho Byun (Gyeongsang National University, Korea, Republic of)
    Keynote
    Hayato Ohshima (Niigata University, Japan)
    Speaker
    Sun-Young Kim (Seoul National University, Korea, Republic of)
    Jin Man Kim (Seoul National University, Korea, Republic of)
    Jung-Bo Huh (Department of Prosthodontics, School of Dentistry, Pusan national university, Korea, Korea, Republic of)
    Chan Ho Park (Kyungpook National University, Korea, Republic of)

    Description

    Regenerative dentistry means the regeneration for damaged odontogenic tissues or their supporting tissues. Supporting portions of the odontogenic tissues include the alveolar bone of the alveolar processes of the maxilla and mandible, periodontal ligaments, and gingiva. Especillary, the success of dental implant in the older ages is heavily based on the healthy supporting tissues. Tissue-engineered regeneration will be discussed for the reconstruction of dentin, pulp, and periodontal ligament in this session. Also, tissue-engineered approaches for long-term success rates of implant placement will be presented.

  • Session Topic
    Immune Engineering
    Session Title
    S4-D_Biomaterials for Immune modulation
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Room 302
    Chair
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Keynote
    Jae Hyung Park (Sungkyunkwan University, Korea, Republic of)
    Speaker
    Jiyoung Song (KIST, Korea, Republic of)
    Aseel Alatoom (New York University Abu Dhabi, United Arab Emirates)
    Sungjun Kim (Department of Chemical & Biochemical Engineering, Dongguk University, Korea, Republic of)

    Description

    The session focuses on various engineered biomaterials for therapeutic immune modulation. This session covers specific topics about biomaterial-mediated exogenous delivery of immune activator, immunomodulators, and biological substances. In addition, a series of immune engineering platforms such as localized imaging technology, self-assembled structures, scaffold/hydrogels for immunomodulation, material-associated cellular manipulation will be also included.

  • Session Topic
    Biofabrication
    Session Title
    S4-E_In vitro models: Processing techniques and applications
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Room 303
    Chair
    J. Miguel Oliveira (University of Minho/3B's Research Group, Portugal)
    Rui L. Reis (University of Minho/3B's Research Group, Portugal)
    Keynote
    Rui L. Reis (University of Minho/3B's Research Group, Portugal)
    Speaker
    J. Miguel Oliveira (University of Minho/3B's Research Group, Portugal)
    Mitchell St Clair-Glover (University of Wollongong, Australia)
    Sunho Park (Chonnam National University, Korea, Republic of)
    Hui-Yu Lin (National Central University, Chinese Taipei)

    Description

    The conventional approaches in research often involve culturing of cells in two dimensional surfaces and animal models, but these were still not fully comparable to human reality/conditions and can result in misleading research data. In the last few years, standardized and high-throughput 3D human tissue in vitro models, the so-called complex in vitro models (CIVMs), has allowed bridging the gap between pre-clinical and clinical trials, by means of enabling overcome the current scientific limitations and mimic the human tissue/organ microenvironment and complexity. The main objective of the symposium on “In vitro Models: Processing techniques and applications” is to provide the attendees the latest developments in the field. A special focus will be given to: the types of CIVMs that can be envisioned, which can include spheroids and microphysiological systems including, organoids (commonly derived from stem cells or other progenitor cells), hydrogels-based in vitro models, scaffolds-based in vitro models, bioprinted of in vitro models, tissue engineered in vitro models, and in vitro models integrated in dynamic culture systems (e.g., microfluidics and bioreactors) such as organ/body-on-chip devices. The recent works related to the applications of the different in vitro models will be also presented herein, in particular in tissue engineering, drug discovery/development, neurosciences, precision medicine and cancer research. Finally, the significant achievements and the current research findings that are drivers for future investigations which can open new possibilities for the design and validation of platforms based on in vitro models will also be discussed.

  • Session Topic
    SYIS
    Session Title
    S4-F_SYIS_Stem cell engineering
    Date & Time
    2022-10-06 13:00~14:30
    Room
    Room 401
    Chair
    Jung Seung Lee (Sungkyunkwan University, Korea, Republic of)
    Hyun Su Park (Sungkyunkwan University, Korea, Republic of)
    Speaker
    Pauline Wosinski (University Paris Cite, CNRS, INSERM ENVA, B3OA, F-75010 Paris, France, France)
    Deogil Kim (CHA University, Korea, Republic of)
    Punn Augsornworawat (Washington University in St. Louis, USA)
    Jeong Seop Park (Kyunghee University, Korea, Republic of)
    Dong Il Shin (Department of Molecular Science and Technology, Ajou University, Suwon, Korea, Republic of, Korea, Republic of)
    Kee-Chin Sia (Institute of Biomedical Engineering, National Tsing Hua University, Chinese Taipei)
    Eun cheol Lee (Sungkyunkwan University, Korea, Republic of)
    Inseon Kim (Laboratory of Regenerative and Movement Biology, Department Health Sciences and Technology, ETH Zurich, Switzerland)
    Ji hoon Jeong (Soonchunhyang Institute of Medi-bio Science (SIMS), Korea, Republic of)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S5-A_Acoustic bioassembly strategies for tissue engineering
    Date & Time
    2022-10-06 14:30~16:00
    Room
    Halla Hall
    Chair
    Tiziano Serra (AO Research Institute Davos, Switzerland)
    Mauro Alini (AO Research Institute Davos, Switzerland)
    Keynote
    Utkan Demirci (Stanford University, USA)
    Speaker
    Tiziano Serra (AO Research Institute Davos, Switzerland)
    Pu Chen (Wuhan University, China)
    Yisheng Cui (Department of Biotechnology, Graduate school of Engineering, Osaka University, Japan)
    Fatin Fazrina Binti Roslan (Advanced Medical and Dental Institute, University of Science Malaysia, Malaysia)

    Description

    The main objective of the symposium is to introduce the TERMIS community to a novel class of biofabrication approaches that intends to revolutionize the way to engineer complex multicellular systems.
    Morphogenesis, a complex process, ubiquitous in developmental biology, regenerative medicine, and many pathologies, is based on self-patterning of cells. Spatial patterns of cells, organoids, inorganic particles can be forced on-demand using acoustic field-based assembly processes. Such contactless methods allow tuning parameters under fast and mild culture conditions, for morphologically relevant tissue generation.
    We believe this symposium will be a unique opportunity to initiate the TERMIS community to emerging sound-wave-driven bioassembly processes which pave the way to a number of applications, ranging from the generation of advanced micro-physiological models for drug screening to novel therapeutics approaches and cell therapy fields. This symposium will attract contribution by all groups interested in Biofabrication, Biomaterials, 3D in vitro modeling. In addition, it will interest all groups investigating extrinsic forces fields and their influence on living cells and tissues.

  • Session Topic
    Biomaterials
    Session Title
    S5-B_Biomaterials for cardiovascular system
    Date & Time
    2022-10-06 14:30~16:00
    Room
    Samda Hall
    Chair
    Jennifer Young (National University of Singapore, Singapore)
    Youngmee Jung (KIST, Korea, Republic of)
    Keynote
    Justin Cooper-White (The University of Queensland, Australia)
    Speaker
    Youngmee Jung (Korea Institute of Science and Technology, Korea, Republic of)
    Jennifer Young (National University of Singapore, Singapore)
    Christy Wing Tung Wong (Institute for Tissue Engineering and Regenerative Medicine, School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China, Hong Kong)
    Steve Waqanivavalagi (University of Auckland, New Zealand)

    Description

    The Cardiovascular Special Interest Group has the mission to foster the professional interaction and address the common concerns of academic and industrial scientists and engineers, clinicians, and regulatory professionals concerned with the discovery, research, development, and use of biomaterials for cardiovascular devices and implants.

  • Session Topic
    Neurobiology
    Session Title
    S5-C_Neurosurgery session 1
    Date & Time
    2022-10-06 14:30~16:00
    Room
    Room 301
    Chair
    Inbo Han (CHA University School of Medicine, CHA Bundang Medical Center, Korea, Republic of)
    Young Seok Park (Chungbuk National University Hospital, Korea, Republic of)
    Keynote
    KiBum Lee (Rutgers University, USA)
    Speaker
    Jeong-Yoon Park (Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Korea, Republic of)
    Kyoung-Tae Kim (Kyungpook National University, Korea, Republic of)
    Kijun Park (Yonsei University, Korea, Republic of)
    Marie Piantino (Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Japan)

    Description

  • Session Topic
    Manufacturing & Bioprocess
    Session Title
    S5-D_Recent technologies for cell manufacturing
    Date & Time
    2022-10-06 14:30~16:00
    Room
    Room 302
    Chair
    Masahiro Kino-oka (Department of Biotechnology, Osaka University; Research Base for Cell Manufacturability, Osaka University, Japan)
    Tatsuya Shimizu (Tokyo Women's Medical University, Japan)
    Keynote
    Tatsuya Shimizu (Tokyo Women's Medical University, Japan)
    Speaker
    Masahiro Kino-oka (Department of Biotechnology, Osaka University; Research Base for Cell Manufacturability, Osaka University, Japan)
    Yeong-Jin Choi (Korea Institute of Materials Science, Korea, Republic of)
    Jeremy Teo (New York University Abu Dhabi, United Arab Emirates)
    Tan Dai Nguyen (Critical Analytics for Manufacturing of Personalized Medicine, Singapore-MIT Alliance for Research and Technology (Singapore), Singapore)

    Description

    Cell manufacturing is the critical step to realize the cell therapy. This symposium covers recent development of manufacturing techniques including not only development of a novel culture system but also construction of automation system and bioreactor as well as management of cell processing facility. In addition, the software to analysis and predict the cell quality and process profile are also critical tools such as monitoring and simulation to realize the stability of process in practical manufacturing.
    This symposium will provide the facilitation of understanding concerning practical cell processing for therapy, supposing to gather the audiences from the broad fields including creators of cell therapy in basic researches, developers of cell manufacturing, operators and managers in cell processing facility.

  • Session Topic
    SYIS
    Session Title
    S5-F_SYIS_Organ-mimetic platforms
    Date & Time
    2022-10-06 14:30~16:00
    Room
    Room 401
    Chair
    Tae-Eun Park (UNIST, Korea, Republic of)
    Minjeong Jang (KIST, Korea, Republic of)
    Speaker
    Dasom Kong (Seoul National University, Korea, Republic of)
    Tia Utami (Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Japan)
    Shiori Tamura (School of Life Science and Technology, Tokyo Institute of Technology, Japan)
    Sungjin Min (Yonsei University, Korea, Republic of)
    Taijun Moriwaki (Keio University, Japan)
    Lina Joo (Department of Microbiology, CHA University School of Medicine, Seongnam, Republic of Korea., Korea, Republic of)
    Wanjing Ou (Tissue Engineering Laboratory, Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong Special Administrative Region, China, Hong Kong)
    Tae Young Kim (yonsei, Korea, Republic of)
    Minjeong Jang (KIST, Korea, Republic of)

    Description

  • Session Topic
    Biofabrication
    Session Title
    S5-E_3D bioprinting of vascularised organs and tissues
    Date & Time
    2022-10-06 14:30~16:10
    Room
    Room 303
    Chair
    Jiao Jiao Li (University of Technology Sydney, Australia)
    Jinah Jang (Pohang University of Science and Technology, Korea, Republic of)
    Keynote
    Carmine Gentile (University of Technology Sydney, Australia)
    Speaker
    Anita Quigley (Biomedical and Electrical Engineering, School of Engineering, RMIT University, Melbourne, VIC 3001, Australia)
    Kris Kilian (UNSW Sydney, Australia)
    Jeonghyun Son (UNIST, Korea, Republic of)
    Shabir Hassan (Khalifa University, United Arab Emirates)
    Ana Luiza Millás (Startup 3D Biotechnology Solutions - 3DBS, Brazil)

    Description

    Objectives: 3D bioprinting provides great potential for recapitulating the complex hierarchical structure of tissues and organs, but key challenges remain. This symposium focuses on the development of 3D bioprinting technology and testing bioprinted products in applications of tissue regeneration, disease modelling, and drug testing, with a specific focus on cardiac and musculoskeletal tissues.

    Key concepts: 3D bioprinting is an area of rapid and exciting development in tissue engineering, consisting of technologies to precisely dispense cell-laden biomaterials for constructing complex and functional living tissues or organs. Compared to traditional biofabrication methods, 3D bioprinting offers unprecedented ability to print bio-constructs with precise control over their composition and spatial distribution, producing biomimetic tissue architecture and properties. Major advances in this area include the development of high-throughput and high-resolution bioprinting technologies with the capability of producing hierarchical, vascularised, thick tissue engineered constructs, as well as novel bioinks that can support native tissue function and encourage integration with host tissues. 3D bioprinting is already demonstrating its potential in generating a range of transplantable tissue constructs, as well as organoids that replicate the function and properties of native tissues, including highly vascularised tissues such as heart, cartilage and bone microtissues.

    Impact and applications: Bioprinted tissues have potential to be used as transplantable grafts to repair or replace damaged tissues, as well as for the development of advanced in vitro models to study tissue pathophysiology and treatments. Despite recent developments, key challenges of current bioprinting approaches remain, such as printing resolution and precision, versatility of cell types and materials, ability to print large and hierarchical constructs, and achieving functional vascularisation and innervation. All of these topics are welcome in this symposium, from advances in the technology of bioprinting to its applications in generating artificial tissues and organs, as well as current challenges and outlook.

  • Session Topic
    Tissue Engineering
    Session Title
    S6-A_Bio-inspired approaches in 3D tissue reconstruction
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Halla Hall
    Chair
    Manuela Gomes (3B’s Research Group - I3Bs - Research Institute of University of Minho, Portugal)
    Kyung Min Park (Incheon National University, Korea, Republic of)
    Organizer
    Heungsoo Shin (Hanyang University, Korea, Republic of)
    Keynote
    Antonios Mikos (Rice University, USA)
    Speaker
    Heungsoo Shin (Hanyang University, Korea, Republic of)
    Min-Soo Ghim (Wonkwang University, Korea, Republic of)
    Gretel Major (University of Otago, New Zealand)
    Paula Nunes de Oliveira (CNRS@CREATE Ltd, Singapore)

    Description

    The properties of the native extracellular matrices (ECM) at different hierarchical scales and its microenvironment are known to play a key role on many biological functions of tissue. Therefore, tissue engineering and regenerative medicine approaches inspired in such concepts have far more potential to lead to advanced tissue substitutes or models that more closely resemble native tissue functionalities and properties. The focus of this symposium will be on emerging designs and 3D fabrication technologies with new functionalities applied in tissue engineering and regenerative medicine as well as in disease modeling. Contributions regarding the development of microfabrication techniques such as three dimensional (3D) bioprinting and advanced bioink biomaterials, but also spheroid-based 3D tissue construction for the development of biomimetic microarchitectures that reproduce the characteristics of the native ECM are of interest of this session. Additionally, this symposium foresees studies on the integration of such systems with drug delivery approaches and/or physical stimulus for achieving better control of the tissue environment and thus improved functionality.

  • Session Topic
    Biomaterials
    Session Title
    S6-B_Nano-biomaterials for regeneration
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Samda Hall
    Organizer
    Youngmee Jung (KIST, Korea, Republic of)
    Chair
    Chong-Su Cho (Seoul National University, Korea, Republic of)
    Ji-Young Hwang (Korea Carbon Industry Promotion Agency, Korea, Republic of)
    Keynote
    Chong-Su Cho (Seoul National University, Korea, Republic of)
    Speaker
    Ji-Young Hwang (Korea Carbon Industry Promotion Agency, Korea, Republic of)
    Young-Min Kim (Korea Institute of Science and Technology, Korea, Republic of)
    Hyojin Lee (Korea Institute of Science and Technology, Korea, Republic of)
    Rajendra Kumar Singh (Dankook University, Korea, Republic of)

    Description

  • Session Topic
    Neurobiology
    Session Title
    S6-C_Neurosurgery session 2
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Room 301
    Chair
    KiBum Lee (Rutgers University, USA)
    Jeong-Yoon Park (Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Korea, Republic of)
    Keynote
    Inbo Han (CHA University, Korea, Republic of)
    Speaker
    Young seok Park (Chungbuk univ, Korea, Republic of)
    Anam Anjum (Center of Tissue Engineering and Regenerative medicine, Faculty of Medicine, University Kebangsaan Malaysia, Jalan Yaacob Latif, 56000 Cheras, Kuala Lumpur, Malaysia)
    Muhammad Shafiq (Department of Chemical Engineering, Faculty of Engineering, Graduate School, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan, Japan)
    Suat Cheng Tan (School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kelantan, Malaysia., Malaysia)

    Description

  • Session Topic
    Manufacturing & Bioprocess
    Session Title
    S6-D_Manufacturing technologies for cell/tissue sources
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Room 302
    Organizer
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Chair
    Tae-Hyung Kim (Chung-Ang University, Korea, Republic of)
    Yoh-ichi Tagawa (Tokyo Institute of Technology, Japan)
    Keynote
    Yoh-ichi Tagawa (Tokyo Institute of Technology, Japan)
    Speaker
    Ying-Chieh Chen (National Tsing-Hua University, Chinese Taipei)
    Jerome Tan Zu Yao (School of Chemical and Biomedical Engineering, Nanyang Technological University, Interdisciplinary Graduate Programme, Singapore)
    Carla Veronica Fuenteslopez (Institute of Biomedical Engineering, University of Oxford, United Kingdom)
    Yejin Youm (Univ. postech, Korea, Republic of)

    Description

  • Session Topic
    Biofabrication
    Session Title
    S6-E_New frontiers in advanced bioinks and biofabrication of functional tissues and organs
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Room 303
    Chair
    Jinah Jang (Pohang University of Science and Technology, Korea, Republic of)
    Khoon Lim (Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, New Zealand)
    Keynote
    Y. Shrike Zhang (Harvard Medical School, USA)
    Speaker
    Jelena Rnjak-Kovacina (University of New South Wales, Australia)
    Carmine Gentile (University of Technology Sydney, Australia)
    Byoung Soo Kim (Pusan National University, Korea, Republic of)
    Xiaoyu Du (ETH Zurich, Switzerland)

    Description

    Bioprinting is recognized as an emerging technology creating multiscale 3D architectures composed of various types of living cells and biomaterials to produce functional tissues and organs expected to be translational in the clinic. To promote scientific exchange and closer networks and collaborative ties among multidisciplinary researchers, we have invited one keynote and four distinguished speakers as new frontiers of 3D bioprinting, bioinks, and its applications in tissue engineering and regenerative medicine. This session will cover cutting-edge research and future perspectives on biofabrication-assisted tissue engineering.

  • Session Topic
    SYIS
    Session Title
    S6-F_SYIS_Mentoring session
    Date & Time
    2022-10-06 16:30~18:00
    Room
    Room 401
    Chair
    Yoonhee Jin (Yonsei University College of Medicine, Korea, Republic of)
    Mikyung Shin (Sungkyunkwan University, Korea, Republic of)
    Mentor
    Guoping Chen (National Institute for Materials Science, Japan)
    Justin Cooper-White (The University of Queensland, Australia)
    James J. Yoo (Wake Forest Institute for Regenerative Medicine, Winston Salem, North Carolina, U.S.A., USA)
    Abhay Pandit (CÚRAM, University of Galway, Ireland)
    Chong-Su Cho (Seoul National University, Korea, Republic of)
    Q&A
    (

    Description

    Special session for career development

  • Session Topic
    Plenary Lecture
    Session Title
    PL3_Plenary Lecture 3
    Date & Time
    2022-10-07 09:00~10:00
    Room
    Halla Hall
    Chair
    Jeong Ok Lim (Kyungpook National University, Korea, Republic of)
    Plenary Speaker
    David Mooney (School of Engineering and Applied Sciences and Wyss Institute, Harvard University, USA)

    Description

  • Session Topic
    Awards Session
    Session Title
    S7-A_2022 TERMIS-AP Awards session
    Date & Time
    2022-10-07 10:30~12:00
    Room
    Halla Hall
    Chair
    Guoping Chen (National Institute for Materials Science, Japan)
    Awardee
    Yasuhiko Tabata (Laboratory of Biomaterials, Institute for Life and Medical Sciences, Kyoto University, Japan)
    Yin Xiao (School of Medicine and Dentistry, Griffith University, Australia)
    Khoon Lim (Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, New Zealand)
    Jiao Jiao Li (University of Technology Sydney, Australia)

    Description

  • Session Topic
    Biomaterials
    Session Title
    S7-B_Polymeric biomaterials for tissue engineering
    Date & Time
    2022-10-07 10:30~12:00
    Room
    Samda Hall
    Organizer
    Youngmee Jung (KIST, Korea, Republic of)
    Chair
    Yoon Ki Joung (KIST, Korea, Republic of)
    Nur Aliana Hidayah Mohamed (Universiti Teknologi MARA, Malaysia)
    Keynote
    Akon Higuchi (National Central University, Chinese Taipei)
    Speaker
    Masaya Yamamoto (Tohoku University, Japan)
    Ki Su Kim (Pusan National University, Korea, Republic of)
    Nik Aliaa (University College London, United Kingdom)
    Yun Kee Jo (Kyungpook National Unviersity, Korea, Republic of)

    Description

  • Session Topic
    Musculoskeletal
    Session Title
    S7-C_Musculoskeletal tissue regeneration
    Date & Time
    2022-10-07 10:30~12:00
    Room
    Room 301
    Chair
    Hyuk-Soo Han (Seoul National University Hospital, Korea, Republic of)
    Martin Stoddart (AO Research Institute Davos, Switzerland)
    Keynote
    Mauro Alini (AO Research Institute, Switzerland)
    Speaker
    Jung-Taek Hwang (Chuncheon Sacred Heart Hospital, Hallym University Medical College, Korea, Republic of)
    Aleksandr Ovsianikov (TU Wien, Austria)
    Chaozong Liu (University College London, United Kingdom)
    Yen-Zhen Lu (European Molecular Biology Laboratory Australia, Australian Regenerative Medicine Institute, Monash University, Australia, Australia)
    Patrina S.P. Poh (Berlin Institute of Health at Charite-universitatmedizin Berlin, Germany)
    Q&A
    (

    Description

    Musculoskeletal degeneration and incomplete recovery from injuries have become more prevalent as people live longer and increasingly participate in rigorous athletic and recreational activities. Additionally, defects in skeletal tissues may immobilize people and cause inflammation and pain, which finally lower people's quality of life and shorten their lifespan. In this session, speakers will review current knowledge, clinical applicaion and future perspectives regarding diverse musculoskeletal tissue regeneration.

  • Session Topic
    Biofabrication
    Session Title
    S7-E_Multiscale printing for biomedical application
    Date & Time
    2022-10-07 10:30~12:00
    Room
    Room 303
    Chair
    Won-Gun Koh (Yonsei University, Korea, Republic of)
    Jae Young Lee (Gwangju Institute of Science and Technology, Korea, Republic of)
    Keynote
    Alexander Revzin (Mayo Clinic, USA)
    Speaker
    Luciano Vidal (Centrale Nantes, France)
    Hwan Kim (Korea National University of Transportation, Korea, Republic of)
    Fiona Louis (Osaka University, Japan)
    Jae Young Lee (Gwangju Institute of Science and Technology, Korea, Republic of)

    Description

    Stimulated by the development of various printing technologies, biofabrication has been playing important role in various biomedical engineering. This session will cover the use of various fabrication techniques to produce complex biomedical materials or devices. Fabrication methods include 2D or 3D printing techniques, while application areas include miniaturized biosensor, tissue engineering scaffold, lab on a chip devices and other micro or nanofabricated biomedical systems.

  • Session Topic
    Enabling Technology
    Session Title
    S7-F_Smart and targeted therapy
    Date & Time
    2022-10-07 10:30~12:00
    Room
    Room 401
    Chair
    Su-Geun Yang (Inha University, Korea, Republic of)
    Sejin Son (Inha University, Korea, Republic of)
    Keynote
    Sejin Son (Inha University, Korea, Republic of)
    Speaker
    Jung-Hoon Park (Asan Medical Center, Korea, Republic of)
    Peerapat Thongnuek (Biomedical Engineering Program, Faculty of Engineering, Chulalongkorn University, Thailand)
    Seokyoung Bang (KIST, Korea, Republic of)
    Behnam Akhavan (University of Newcastle, Australia)

    Description

    In order to enhance the therapeutic effect and reduce the associated side effects, drug molecules should be selectively accumulated at the targert tisseu for a long time with high controllability. Smart and targerted drug delivery refers to approaches, formulations, technologies and systems for transporting therapeutic agents into the body as needed to safely and efficiently achieve a desired therapeutic effect. Currently, new concnetional desing for targeted drug delivery, such as flexiable mdeical devices, biosystem responsive molecules and etc have been tried in academica area and quickly moves to clinical areas. This session will discusss current scientific achivements for Smart and Targeted Drug Therapy.

  • Session Topic
    KWSE Session
    Session Title
    S7-D_KWSE session
    Date & Time
    2022-10-07 10:30~12:30
    Room
    Room 302
    Chair
    Jeong Ok Lim (Kyungpook National University, Korea, Republic of)
    Ji-Young Hwang (Korea Carbon Industry Promotion Agency (KCARBON), Korea, Republic of)
    Keynote
    Pamela C Yelick (Tufts University, USA)
    Speaker
    Wonhee Suh (Chung-Ang University, Korea, Republic of)
    Soo Yeon Jung (Ewha Womans University, College of Medicine, Korea, Republic of)
    Seunghee Lee (Kangstem Biotech, Korea, Republic of)
    Panel Discussion
    Prof. Jeong Ok Lim, Dr. Ji-Young Hwang, Dr. Pamela C Yelick, Prof. Wonhee Suh, Prof. Soo Yeon Jung, Dr. Seunghee Lee (

    Description

    1) Objectives: To secure source proprietary technologies and commercialization strategies in the fields of advanced tissue engineering and regenerative medicine, we would like to hold a symposium for women scientists and engineers. It aims to strengthen the continuous collaboration foundation for industry-academic research networks of domestic and international female participants.
    2) Key concept and related contents: Through a plenary lecture, invited presentations, and panel discussions by excellent women scientists or engineers, we will share the latest research results, lead mentoring programs, and secure core technologies and commercialization in the fields of tissue engineering and regenerative medicine to contribute to global health.

  • Session Topic
    Joint Sesion
    Session Title
    S8-A_KFRM joint session: Domestic and global interaction in cell therapy industry
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Halla Hall
    Organizer
    Yoon-Hyuk Choe (KFRM, Korea, Republic of)
    Chair
    Inho Jo (KFRM, Korea, Republic of)
    Jeong Ok Lim (Kyungpook National University, Korea, Republic of)
    Keynote
    J. Kelly Ganjei (Amplifybio, USA)
    Speaker
    Jaeseung Lim (Cellatoz Therapeutics, Inc., Korea, Republic of)
    Sung Hyun Choi (AFX R&D Center, AffyXell Therapeutics Co., Ltd., Korea, Republic of)
    Minhee Kim (Central Research Center, Corestem Inc., Korea, Republic of)
    Mincheol Kim (K&L Gates, LLP, USA)
    Hanah Cho (Korean Fund for Regenerative Medicine, Korea, Republic of)

    Description

  • Session Topic
    Biomaterials
    Session Title
    S8-B_Biomaterials for regenerative engineering
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Samda Hall
    Chair
    Andrew Holle (National University of Singapore, Singapore)
    Youngmee Jung (KIST, Korea, Republic of)
    Keynote
    Abhay Pandit (CÚRAM, University of Galway, Ireland)
    Speaker
    Su-Jin Heo (University of Pennsylvania, USA)
    Andrew Holle (National University of Singapore, Singapore)
    Kee Woei Ng (Nanyang Technological University, Singapore)
    Kye Il Joo (Ewha Womans University, Korea, Republic of)

    Description

    Regenerative engineering aims to develop functional, bioactive, and instructive biomaterials and approaches for the regeneration of tissues through a convergence of engineering, medicine, developmental biology, and stem cell science. This symposium will highlight recent trends in developing functional biomaterials that play an active role in controlling cellular behaviors and tissue regeneration. During the symposium, translational strategies for handling these biomaterials from ‘Bench to Bedside’ will also be addressed.

  • Session Topic
    Musculoskeletal
    Session Title
    S8-C_Cell therapy for cartilage repair and osteoarthritis (KORS joint session)
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Room 301
    Chair
    Hyuk-Soo Han (Seoul National University Hospital, Korea, Republic of)
    Chul-Won Ha (Sungkyunkwan University, Korea, Republic of)
    Keynote
    Martin Stoddart (AO Research Institute Davos, Switzerland)
    Speaker
    Min Jung (Yonsei University College of Medicine, Korea, Republic of)
    Yong-Beom Park (Chung-Ang University, Korea, Republic of)
    Zheng Yang (National University of Singapore, Singapore)
    Maryam Tamaddon (University College London, United Kingdom)
    Seok Jung Kim (The Catholic University of Korea, Korea, Republic of)
    Q&A
    (

    Description

    Osteoarthritis (OA) is a chronic, prevalent, debilitating joint disease characterized by progressive cartilage degradation, subchondral bone remodeling, bone marrow lesions, meniscal damage, and synovitis. OA is directed toward symptomatic treatment, mainly pain management, and is not able to promote regeneration of degenerated cartilage or to attenuate joint inflammation. Since articular cartilage have no ability to heal, regeneration of cartilage injury remains one of the most important goals of new therapeutic approaches used for OA treatment. In this session, speakers will review current knowledge, clinical applicaion and future perspectives regarding cell therapy for cartilage repair and the treatment of OA.

  • Session Topic
    Biomaterials
    Session Title
    S8-D_Natrual compound-based biomaterials
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Room 302
    Organizer
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Chair
    Ki Su Kim (Pusan National University, Korea, Republic of)
    Kwideok Park (Korea Institute of Science and Technology, Korea, Republic of)
    Keynote
    Nam Joon Cho (Nanyang Technological University, Singapore)
    Speaker
    Jungsil Kim (Sunchon National University, Korea, Republic of)
    Dayamon Mathew (Banaras Hindu University, India)
    Chul Ho Jang (Chonnam National University, Korea, Republic of)
    Jasmine Seah (Nanyang Technological University, School of Materials Science and Engineering, Singapore)

    Description

  • Session Topic
    Stem Cells
    Session Title
    S8-E_Recent advances in stem cell applications
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Room 303
    Organizer
    Jongpil Kim (Dongguk University, Korea, Republic of)
    Chair
    Byung Hyune Choi (Council for Advanced Regenerative Medicine (CARM), Inha University College of Medicine, Korea, Republic of)
    Won-Young Cho (Seoul National University Hospital, Korea, Republic of)
    Speaker
    Won-Young Cho (Seoul National University Hospital, Korea, Republic of)
    Myung-Seo Kim (Kyung Hee University, Korea, Republic of)
    Fazlina Nordin (Centre for Tissue Engineering and Regenerative Medicine (CTERM), Universiti Kebangsaan Malaysia (UKM), Malaysia)
    Jun-Yeol Park (Department of Microbiology, CHA University School of Medicine, Seongnam, Republic of Korea., Korea, Republic of)
    Seong-Woo Maeng (Department of Chemical Engineering, Pohang University of Science and Technology, Pohang 37673, Korea, Korea, Republic of)

    Description

  • Session Topic
    Enabling Technology
    Session Title
    S8-F_Recent advances in bioprinting technologies for tissue engineering
    Date & Time
    2022-10-07 13:00~14:30
    Room
    Room 401
    Chair
    Daniel Nieto (MERLN Institute for Technology-Inspired Regenerative Medicine, Netherlands)
    Keynote
    Daniel Nieto (Maastricht University, Netherlands)
    Speaker
    Amir K. Miri (New Jersey Institute of Technology, USA)
    Hossein Goodarzi Hosseinabadi (Bayreuth University, Germany)
    Laura Vettori (University of Technology Sydney, Australia)
    Joshua Jaeyun Kim (ROKIT HEALTHCARE, Inc, Korea, Republic of)

    Description

    Light based bioprinting has been actively investigated as one of the enabling technologies for the impending era of personalized medicine. These technologies, which use light for polymerization of biomaterials, have made significant progress in the quality, resolution and generation of precise complex tissue structures. Numerous fields have been disrupted by its introduction, such as tissue engineering and regenerative medicine. This is often attributed to the technology’s inherent versatility, unique ability to fabricate intricate designs, and cost-effectiveness compared to traditional manufacturing processes. This symposium will focus on the most common light-based technologies using photopolymerization including, Laser-based SLA, Mask-based SLA, Digital Light Projection (DLP), two-photon bioprinting (TTP), laser induced forward transfer (LIFT), laser-direct bioprinting (LDP), Volumetric 3D printing and any other novel light based bioprinting and biofabrication approaches; and their application to tissue engineering and regenerative medicine. In recent years, the evolution of these technologies has been growing along with the development of new photocurable resins and photoinitiators that are biocompatible and biodegradable with bioactive properties. Such evolution has allowed the progress of a large number of tissue engineering applications. With the broad application of 3D microstructures in the biomedical field, this symposium will also pay attention to the physicochemical properties of the resulting tissue structures, such as biocompatibility, biodegradability, stimuli responsiveness and immunogenicity.

  • Session Topic
    Tissue Engineering
    Session Title
    S9-A_Tissue regenerative platforms for cartilage joints
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Halla Hall
    Organizer
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Chair
    Yoonhee Jin (Yonsei University College of Medicine, Korea, Republic of)
    James Goh (Biomedical Engineering, National University of Singapore, Singapore)
    Keynote
    James Goh (Biomedical Engineering, National University of Singapore, Singapore)
    Speaker
    Chaozong Liu (University College London, United Kingdom)
    Zhong Alan Li (The Chinese University of Hong Kong, Hong Kong)
    Laura Veenendaal (University of Otago, New Zealand)
    Jiao Jiao Li (University of Technology Sydney, Australia)

    Description

  • Session Topic
    Biomaterials
    Session Title
    S9-B_Biofunctional hydrogels to direct cell fate & tissue regeneration
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Samda Hall
    Chair
    Catherine Le Visage (Nantes Université, France)
    Junmin Lee (POSTECH, Korea, Republic of)
    Keynote
    Sing Yian Chew (Nanyang Technological University, Singapore)
    Speaker
    Ayse Kose (Prometheus Division of Skeletal Tissue Engineering, KU Leuven, Belgium; Skeletal Biology and Engineering Research Center, KU Leuven, Belgium; Biomechanics Section, KU Leuven, Belgium, Belgium)
    Ashley Nguyen (University of New South Wales, Australia)
    Victor Leung (The University of Hong Kong, Hong Kong)
    Yen-Hung Chen (National Central University, Chinese Taipei)

    Description

    The field of hydrogels for TERM applications is a prolific area of research with applications for most bodily tissues. Over the last decade, scientists have incorporated biological (growth factors, cytokines) and biophysical (substrate topography, material stiffness, degradable sequences) cues as a mean to better understand cell/scaffold interactions as well as enhancing therapeutic outcomes.
    With this symposium, we aim to gather scientists and clinicians to address these new developments and highlight both basic science studies and recent translational applications. For this we have invited renowned researchers in the field who will share their work on different aspects related to hydrogels and cell fate.
    The keynote presentations will showcase recent advances, covering both chemical and biological aspects of the design of biofunctionalized hydrogels, that are able to recapitulate some of the fundamental cues of native environments to drive the local tissue regeneration. More specifically, the keynote speakers will focus on recent regenerative applications of hydrogels on understanding and controlling stem/progenitor cell fate, as well as in vivo neural tissue regeneration. (Prof. Sing Yian CHEW, Singapore).
    All in all, with this symposium we would like to provide an overview picture of the latest advancements regarding the use of hydrogels for tissue repair. This symposium will target a diverse audience of students and young scientists, as well as experts from both academia and industry, working in the field of biomedical hydrogels.

  • Session Topic
    Joint Sesion
    Session Title
    S9-C_KSBMT joint sesion
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Room 301
    Chair
    Kyung-Nam Koh (Asan Medical Center, Korea, Republic of)
    Byung Hyune Choi (Inha University, Korea, Republic of)
    Keynote
    Sung-Hoon Jung (Chonnam National University Hwasun Hospital, Korea, Republic of)
    Speaker
    Nayoung Kim (Asan Institute for Life Sciences, Korea, Republic of)
    Yoon Seok Choi (Ajou University School of Medicine, Korea, Republic of)
    Sehwan Jeong (Dongguk Univ., Korea, Republic of)
    Jihye Hong (Seoul National University, Korea, Republic of)

    Description

  • Session Topic
    Biomaterials
    Session Title
    S9-D_Biomaterials for bone and cartilage regeneration
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Room 302
    Organizer
    Youngmee Jung (KIST, Korea, Republic of)
    Chair
    Kwideok Park (KIST, Korea, Republic of)
    Yasuhiko Iwasaki (Kansai University, Japan)
    Keynote
    Yasuhiko Iwasaki (Kansai University, Japan)
    Speaker
    EunAh Lee (Medical Science Research Institute, Kyung Hee University Medical Center/ Impedance Imaging Research Center, Kyung Hee University, 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, South Korea., Korea, Republic of)
    Honghyun Park (Korea Institute of Materials Science (KIMS), Korea, Republic of)
    Jeong-Ho Yun (Jeonbuk National University College of Dentistry, Korea, Republic of)
    Chaozong Liu (University College London, United Kingdom)

    Description

  • Session Topic
    Stem Cells
    Session Title
    S9-E_Next generation biomaterials for Stem cell culture and differentiation
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Room 303
    Chair
    Akon Higuchi (National Central University, Chinese Taipei)
    Guoping Chen (National Institute for Materials Science, Japan)
    Keynote
    Guoping Chen (National Institute for Materials Science, Japan)
    Speaker
    Akon Higuchi (National Central University, Chinese Taipei)
    Retno Wahyu Nurhayati (Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia, Indonesia)
    Manju Shrestha (Sungkyunkwan University, Korea, Republic of)
    Yoojung Lee (Dongguk University, Korea, Republic of)

    Description

    There is a shortage of tissues and organs for patients who suffer damage or loss of their tissues and organs. Stem cells hold promise for drug discovery and regenerative medicine. We would like to propose the symposium of “Biomaterials for Stem Cell Culture and Differentiation for Stem Cell Therapy”. The development of a fully defined microenvironment for culturing and differentiating human stem cells will have a great effect on the use of stem cells in cell therapy and tissue engineering. In this symposium, we will discuss the design and strategy of biomaterials for stem cell culture and differentiation. Especially, we will discuss biomaterial design and preparation that can not only maintain the pluripotency and stemness of human stem cells, but also guide differentiation of stem cells (adult stem cells, fetal stem cells, human embryonic stem cells and human induced pluripotent stem cells) into specific lineages of cells (osteoblasts, chondrocytes, adipocytes, mesenchymal stem cells (from human pluripotent stem cells), hematopoietic stem cells (from human pluripotent stem cells), retinal pigment epithelium (from human pluripotent stem cells) and cardiomyocytes). We will further focus on the effects of physical cues (elasticity, micropatterning, electrical field and mechanical force), together with the biomaterials used in clinical application using stem cells and the translational development of stem cell therapies in various catastrophic illnesses including COVID-19 infection treated by hematopoietic stem cells.

  • Session Topic
    Organoids
    Session Title
    S9-F_Organoid for disease modeling
    Date & Time
    2022-10-07 14:30~16:00
    Room
    Room 401
    Chair
    Yongsung Hwang (Soonchunhyang University, Korea, Republic of)
    Jin Woo Lee (Gachon University, Korea, Republic of)
    Keynote
    Yong Kyun Kim (Cell Death Disease Research Center, College of Medicine, The Catholic University of Korea/Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Korea, Republic of)
    Speaker
    Dong-Hun Woo (NEXEL Co., Ltd., Korea, Republic of)
    Seok-Ho Hong (Department of Internal Medicine, School of Medicine, Kangwon National University, Korea, Republic of)
    Anam Anjum (Center of Tissue Engineering and Regenerative medicine, Faculty of Medicine, University Kebangsaan Malaysia, Jalan Yaacob Latif, 56000 Cheras, Kuala Lumpur, Malaysia)
    Kyoung-ha So (Seoul National University, Korea, Republic of)

    Description

    Recent advances in the patient stem cell-derived 3D human organoids have been used to study vairous diseases, including genetic disorders, degenerative diseases, and cancers, and provide researchers with new opportunities to understand the pathophysiology of the diseases. In this session, we aim to introduce the recent findings on patient-derived 3D organoid platforms to simulate various disease modelings in vitro.

  • Session Topic
    Biomaterials
    Session Title
    S10-B_A partnership between natural biomolecules and biomaterials: towards new surface functionalities
    Date & Time
    2022-10-07 16:30~18:00
    Room
    Samda Hall
    Chair
    Silvia Spriano (Politecnico di Torino, Italy)
    Jun Shik Choi (Korea Institute of Radiological & Medical Sciences (KIRAMS), Korea, Republic of)
    Keynote
    Silvia Spriano (Politecnico di Torino, Italy)
    Speaker
    Junmin Lee (POSTECH, Korea, Republic of)
    Madhusudana Kummara (School of Chemical Engineering and Research Institute of cell culture, Yeungnam University, Gyeongsan-38541, Republic of Korea, Korea, Republic of)
    Ji-Young Hwang (Korea Carbon Industry Promotion Agency, Korea, Republic of)
    Masahiko Nakamoto (Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Japan)

    Description

    The key concept of this symposium is that several molecules or compounds of natural origin are of great i nterest to add specific surface functionalities to implant biomaterials. Phenolic compounds, proteins, vitam ins, essential oils, polymers derived from plants or animals can be used for different targets. The modified surfaces can have ability to enhance and fast the tissue integration, to fight or to reduce the risk of infectio ns, to guide the tissue growth, to modulate the inflammatory response, as an example.
    Different strategies can be followed for modifying the surface: grafting of a molecular monolayer (functio nalization), thin or thick continuous coatings. Different substrates (metals, ceramics, glasses, polymers) ca n be used and pre-treatments can be eventually needed to make the surface suitable to chemically link the natural molecules or compounds. The selection of the processing way must be guided by the chemistry of the surface and ligands as well as by the expected mechanism of action of the biomolecule: progressive rel ease or permanent link to the surface. Functionalization or coating can be coupled to different surface topo graphy of the substrate for a synergic chemical-physical effect on the host response.
    New experimental techniques and characterization protocols are needed for these surfaces in order to test t he effective presence of the biomolecules, the action in biological environments, and to understand the inv olved mechanisms. Post-processing (packaging, sterilization, storage) of the final products must be adapte d to the presence of the biomolecules, too.
    The objective of the symposium is to create a chance for researchers to share their scientific expertise abou t this topic and to dialogue with the industrial manufacturers of implants about the potentiality of this appr oach for a future generation of products. Potential applications are in orthopedic, dental, cardiovascular im plants.

  • Session Topic
    Obstetrics and Gynecology
    Session Title
    S10-C_Regeneration of reproductive tissues and organs
    Date & Time
    2022-10-07 16:30~18:00
    Room
    Room 301
    Chair
    Seung-Yup Ku (Seoul National University Hospital, Korea, Republic of)
    Chun-Ho Kim (KIRAMS, Korea, Republic of)
    Keynote
    Sara Bandstein (Laboratory for Transplantation and Regenerative Medicine, Department of obstetrics and Gynecology, Sahlgrenska Academy, University of Gothenburg, Kvinnokliniken, Blu00e5 stru00e5ket 6, 413 45, Gu00f6teborg, Sweden, Sweden)
    Speaker
    Edina Sehic (Gothenburg University, Sahlgrenska Academy, Sweden)
    Jae Ho Lee (CHA University, Korea, Republic of)
    Yoon Young Kim (Seoul National University Hospital, Korea, Republic of)
    Yong Jin Kim (Korea University, Korea, Republic of)

    Description

    The 2022 TERMIS-AP Congress will be held in Jeju island, South Korea from Oct May 5 to 8, 2022. This meeting plans to invite the experts of reproductive tissue engineering to the section of “Regeneration of Reproductive Tissues and Organs”. This session emphasizes on the recent scientific issues for communications and networking of particular interests among the community which includes focused presentations with high interest regarding emerging topics. Reproductive tissues are essential the fertility, which needs new engineering approaches to overcome the current therapeutic limitations. This session will be the sharing moment of findings newly made and inspire the many researchers working in this emerging field.

  • Session Topic
    Biomaterials
    Session Title
    S10-D_Biomaterials-mediated drug delivery strategies
    Date & Time
    2022-10-07 16:30~18:00
    Room
    Room 302
    Chair
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Yasuhiko Tabata (Laboratory of Biomaterials, Institute for Life and Medical Sciences, Kyoto University, Japan)
    Keynote
    Yasuhiko Tabata (Laboratory of Biomaterials, Institute for Life and Medical Sciences, Kyoto University, Japan)
    Speaker
    Angela MH Ng (Universiti Kebangsaan Malaysia, Malaysia)
    James Lai (Department of Bioengineering, University of Washington, USA)
    Jihyun Seong (Dongguk university, Korea, Republic of)
    Slgirim Lee (Yonsei University, Korea, Republic of)

    Description

  • Session Topic
    Stem Cells
    Session Title
    S10-E_Gene editing and manipulation for stem cell engineering and regenerative medicine
    Date & Time
    2022-10-07 16:30~18:00
    Room
    Room 303
    Chair
    Yu-Chen Hu (National Tsing Hua University, Chinese Taipei)
    Keynote
    Yu-Chen Hu (National Tsing Hua University, Chinese Taipei)
    Speaker
    Pavel Makarevich (Lomonosov Moscow State University, Russia)
    Anh Vu Truong (National Tsing Hua University, Chinese Taipei)
    Yoon Jae Lee (Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Korea, Korea, Republic of)

    Description

    Gene editing by CRISPR and gene regulation by microRNA or CRISPR activation have dramatically changed the way to manipulate cellular gene expression and cell fate. In recent years, various gene editing and gene manipulation technologies have been applied to control stem cell differentiation to enhance tissue regeneration. The primary objective of this symposium is to bring researchers in the gene editing and gene regulation field together to present their research in the application of these burgeoning technologies in stem cell differentiation. This symposium welcomes presentations in the topics of CRISPR, CRISPR activation (CRISPRa), CRISPR inhibition (CRISPRi), RNAi, microRNA, long non-coding RNA and all relevant technologies and their applications to control cell differentiation and tissue regeneration. We expect that this symposium can promote the exchange of new ideas and advancement of regenerative medicine. This is a new field that is very hot in Europe and the US. The main organizer Prof. Yu-Chen (Andy) Hu is the Program Chair of TERMIS-AP, 2016. Prof. Hu is not only experienced in organizing conferences and symposiums, but also well connected with experts in these fields. We will invite speakers from Europe and the US, hoping that the symposium can also promote the collaborations between researchers in TERMIS-AP, TERMIS-EU and TERMIS-AM.

  • Session Topic
    Organoids
    Session Title
    S10-F_Organoid for tissue regeneration
    Date & Time
    2022-10-07 16:30~18:00
    Room
    Room 401
    Chair
    Yongsung Hwang (Soonchunhyang University, Korea, Republic of)
    Yu Suk Choi (University of Western Australia, Australia)
    Keynote
    Tim Woodfield (CReaTE Group, Department of Orthopaedic Surgery & Musculoskeletal Medicine, Centre for Bioengineering & Nanomedicine,University of Otago Christchurch, New Zealand)
    Speaker
    Yu Suk Choi (University of Western Australia, Australia)
    Jeonghyun Kim (Nagoya University, Japan)
    Armin Dadafshar (ORGANOIDSCIENCES Ltd., Korea, Republic of)
    Seong Keun Kwon (Seoul National University Hospital, Korea, Republic of)

    Description

    Human patient stem cell-derived 3D organoids have shown to provide a regenerative potential for vairous diseases, including genetic disorders, degenerative diseases, and cancers, and provide researchers with new opportunities to regenerate the the diseases. In this session, we aim to introduce the recent findings on how patient-derived 3D organoids could regenerate various diseases.

  • Session Topic
    Joint Sesion
    Session Title
    S10-A_CARM joint session
    Date & Time
    2022-10-07 16:30~18:10
    Room
    Halla Hall
    Chair
    Kyung-Sun Kang (Seoul National University, Korea, Republic of)
    Byung Hyune Choi (Inha University, Korea, Republic of)
    Keynote
    Kyung-Sun Kang (Seoul National University, Korea, Republic of)
    Speaker
    Hyejin Kim (ORGANOIDSCIENCES, LTD, Korea, Republic of)
    Hyun-Sook Park (CEFO Co., Ltd., Korea, Republic of)
    Yongsoon Kim (HAPLN SCIENCE, Korea, Republic of)
    Chi Young Chang (YOUTH BIO GLOBAL, Korea, Republic of)
    Jimmy Lee (Xcell Therapeutics, Korea, Republic of)
    Byung Hyune Choi (Council for Advanced Regenerative Medicine (CARM), Inha University College of Medicine, Korea, Republic of)

    Description

  • Session Topic
    FTERM Session
    Session Title
    How can TERMIS make a real impact on regenerative medicine within the next 10 years?
    Date & Time
    2022-10-07 18:10-18:50
    Room
    Halla Hall
    Chair
    Geoff Richards (AO Research Institute Davos, Switzerland)
    Panel
    Mauro Alini (AO Research Institute, Switzerland)
    Manuela Gomes (3B's Research Group - University of Minho, Portugal)
    Rui L. Reis (University of Minho/3B's Research Group, Portugal)
    Abhay Pandit (CÚRAM, University of Galway, Ireland)
    Yasuhiko Tabata (Institute for Life and Medical Sciences, Kyoto University, Japan)
    Jin Ho Lee (Hannam University, Korea, Republic of)
    Hai Bang Lee (, Korea, Republic of)

    Description

    ☆ FTERM open session discussion For all participants Halla Hall ☆

    In open discussion panel session, the audience are invited to ask questions within this topic (How can TERMIS make a real impact on regenerative medicine within the next 10 years) to the fellows.
    We would like to make this session as interactive as possible and are happy for audience participation.
    R.Geoff Richards, Chair of the FTERM

    INTERNATIONAL FELLOWS OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE (FTERM)
    The International Fellows of Tissue Engineering and Regenerative Medicine (FTERM) was created to recognize a distinguished leader within the tissue engineering and regenerative medicine field. FTERM was established to recognize an individuals role in shaping the tissue engineering and regenerative medicine field and TERMIS.

    • Honorary status to recognize individuals that have made outstanding contributions to the field of TERM, with outputs of clear professional excellence.
    • The distinguished members of TERMIS that are recognized as Fellows should be role models for members of the Society and others in the field.
    • Fellows are expected to foster new activities and continue to act as leaders in the field, supporting its development.

    FTERM Panel
    Prof Geoff Richards (Past President and chair of the International Fellows of TERMIS (FTERM))
    Prof. Mauro Alini
    Prof. Manuela Gomes
    Prof. Rui L. Reis (Past chair of FTERM)
    Prof. Abhay Pandit
    Prof Yasahiko Tabata
    Prof. Jin Ho lee
    Prof. Hai Bang Lee

    https://termis.org/international-fellows-tissue-engineering-and-regenerative-medicine-fterm

  • Session Topic
    Plenary Lecture
    Session Title
    PL4_Plenary Lecture 4
    Date & Time
    2022-10-08 09:00~10:00
    Room
    Halla Hall
    Chair
    Inho Jo (Korean Fund for Regenerative Medicine, Korea, Republic of)
    Plenary Speaker
    Youngsook Son (Department of Genetic Engineering, Graduate School of Biotechnology, Kyung Hee University Director of Kyung Hee Institute of Regenerative Medicine (KIRM), Kyung Hee University Hospital, Seoul, Korea, Korea, Republic of)

    Description

  • Session Topic
    Tissue Engineering
    Session Title
    S11-A_Combination technology of cell & biomaterials for effective tissue repair
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Halla Hall
    Chair
    Kyobum Kim (Dongguk University, Korea, Republic of)
    Mikolaj Ogrodnik (Ludwig Boltzmann Research Group SHoW - Senescence and Healing of Wounds, Austria)
    Keynote
    Mikolaj Ogrodnik (Ludwig Boltzmann Research Group SHoW - Senescence and Healing of Wounds, Austria)
    Speaker
    Yundong Koo (CHA University, Korea, Republic of)
    Mh Busra Fauzi (Centre for Tissue Engineering and Regenerative Medicine (CTERM), Faculty of Medicine, Universiti Kebangsaan Malaysia., Malaysia)
    Deepak Choudhury (BTI A*STAR, Singapore)
    Wonjeong Lee (Dongguk University, Korea, Republic of)
    Balaram Mishra (National Institute of Technology Rourkela, India)
    Mou Seung Kim (Department of Biomedical Convergence, School of Convergence, Kyungpook National University, Daegu 41566, Korea, Republic of)

    Description

  • Session Topic
    Biomaterials
    Session Title
    S11-B_Nanomedicine: The impact of nanotechnology on tissue engineering and regenerative medicine
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Samda Hall
    Organizer
    Youngmee Jung (KIST, Korea, Republic of)
    Chair
    Yongsung Hwang (Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Republic of Korea, Korea, Republic of)
    Keynote
    Thomas Webster (Hebei University of Technology, USA)
    Speaker
    Jin Yoo (Korea Institute of Science and Technology, Korea, Republic of)
    So Young Yoo (Pusan National University, Korea, Republic of)
    Luminita Labusca (National Institute of Research and Development in Technical Physics, Romania)
    Zheng Yang (National University of Singapore, Singapore)
    Seunghun S. Lee (Institute for Biomechanics, Department of Health Science and Technology, ETH Zurich, Switzerland)
    Yongsung Hwang (Soonchunhyang Institute of Medi-bio Science (SIMS), Soonchunhyang University, Republic of Korea, Korea, Republic of)

    Description

    Nanomedicine is the use of nanomaterials in medicine. Nanomaterials are broadly defined as materials with at least one dimension less than 100 nm. Due to their small size, nanomaterials can have higher surface energy, penetrate tissues and cells, and can avoid immune system clearance to last longer in the circulatory system. Nanomedicine has already revolutionized disease prevention, diagnosis, and treatment across many parts of healthcare. Diseases in which nanomedicine has impacted medicine include COVID-19 (through the development of vaccines), cancer, diabetes, infection, and tissue engineering. The objective of this symposium is to highlight the recent advances that nanomedicine has made towards improving the design, testing, and use of tissue engineered materials to treat a wide range of diseases. It will highlight various nanomaterials including particles, tubes, fibers, meshes, and other structures. It will also highlight various state-of-the-art manufacturing processes, such as 3D and 4D printing, electrospinning, polymer extrusion, and more. It seeks to also emphasize post-processing nanotexturing such as the use of atomic layer deposition, chemical etching, embedding nanoparticles, e-beam lithography, and more that have been shown to control cell responses. Up-and-coming future areas of nanomedicine will also be emphasized such as the incorporation in implantable sensors into tissue engineering materials to monitor and control tissue healing. Lastly, this symposium will highlight various medical applications including orthopedics, cardiovascular, neurological, cancer, infection, etc. As such, this symposium will highlight an up-and-coming area of tissue engineering and regenerative medicine in nanomedicine providing critical data for the field to continue to grow.

  • Session Topic
    Stem Cells
    Session Title
    S11-C_Stem cell-based therapies - bench-to-bedside
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Room 301
    Organizer
    Kapil Bharti (National Institutes of Health (NIH), USA)
    Chair
    Jihwan Song (CHA University / iPS Bio, Korea, Republic of)
    Tea Soon Park (NIH, USA)
    Keynote
    Kapil Bharti (NIH, USA)
    Speaker
    Jung-Hyun Kim (Korea National Institute of Health, Korea, Republic of)
    Tea Soon Park (NIH, USA)
    Hyewon Chung (Konkuk University School of Medicine, Korea, Republic of)
    Jihwan Song (CHA University / iPS Bio, Korea, Republic of)
    Sungmi Jeon (Seoul National University, Korea, Republic of)
    Xingxing Yang (Tissue Engineering Laboratory, Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong, China, Hong Kong)

    Description

    Induced pluripotent stem cells (iPSCs) provide immune-compatible autologous replacement tissue for the treatment of potentially all degenerative diseases. Several groups are interested in developing autologous and allogeneic iPSC based therapies for degenerative diseases. However, major challenges remain in translating these therapies into clinic. There are challenges to develop clinical grade iPSC lines, how to quality control them and test the derived product for preclinical and clinical use. The main goal of this symposium is to discuss approaches various groups are taking to develop a regulatory compliant path to develop an IPSC based cell therapy and highligh some of the major challenges that lie ahead of us.

  • Session Topic
    Biomaterials
    Session Title
    S11-D_Biomaterials for 3D in vitro tissue-engineered cancer/disease models
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Room 302
    Chair
    Rui L. Reis (3B's Research Group, I3Bs, Portugal)
    Serena Danti (University of Pisa, Italy)
    Keynote
    Serena Danti (University of Pisa, Italy)
    Speaker
    Subha Rath (IIT Hyderabad, India)
    Ipsita Roy (University of Sheffield, United Kingdom)
    Zheng Wang (Huazhong University of Science and Technology, China)

    Description

    Investigators will get an opportunity to know the current methodologies and technologies for developing and using biomaterial-based matrices for 3D cellular and cancer/disease models. In vitro 3D cell culture techniques mimic in vivo tissue microenvironment. The scaffolds are explored to develop highly realistic 3D in vitro tumor/disease models for therapeutic screening and studying disease microenvironment dynamics. Technologies will provide a means to engineer in vitro tumor/disease microenvironment and cell migration to study cancer and other diseases. Advances in scaffold/matrices fabrications using natural and blend materials, 3D bioprinting using bio-ink, micro-patterning, bio-detection/biosensing of cancer diagnostics, and microfluidic devices for the study of cell migrations (e.g. tumor cell invasion, intravasation, and extravasation), tissue growth, including properties of biomaterial matrices, like detection and imaging materials are also within the scope. The state-of-art of emerging technologies to deeper investigate cancer/disease and/or innovative treatments using in vitro 3D models are the demand of the current edge and of practical uses for therapies will be discussed.
    Graduate and postgraduate students and experienced researchers in biotechnology and biomedical engineering working in natural or synthetic biomaterials, drug deliveries, emerging technologies, tissue engineering and regenerative medicine applied to cancer/diseases and/or development comprises the audience of this symposium. Those are working with natural and micro-nano composite biomaterials, in vitro microenvironment modulations, 3D cell culture, cell-based bio-inks, 3D tumor/disease modeling, nanoparticle-based delivery vehicle, micro-patterning, and drug screening using emerging technologies like microfluidics, bio-printing, tumor lab-on-a chip, spheroids, organoids and micro-tissues.

  • Session Topic
    Stem Cells
    Session Title
    S11-E_New frontiers in stem cells and novel biomaterials based regenerative therapies
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Room 303
    Chair
    Sanjiv Dhingra (University of Manitoba, Canada)
    Chieh-Cheng Huang (National Tsing Hua University, Chinese Taipei)
    Keynote
    Young-sup Yoon (Emory University, USA)
    Speaker
    Sanjiv Dhingra (St. Boniface Hospital Research Centre, University of Manitoba, Canada)
    Prasanna Krishnamurthy (University of Alabama at Birmingham, USA)
    Yi-Chen Li (Feng Chia University, Chinese Taipei)
    Chieh-Cheng Huang (Institute of Biomedical Engineering, National Tsing Hua University, Chinese Taipei)
    Jinho Park (Ajou university, Korea, Republic of)

    Description

    Induced pluripotent stem cells (iPSCs) and biomaterial-based approaches have shown significant promise in regenerating and repairing the injured organs including heart, brain, spinal cord and pancreas. Even though the field remains in a relative infancy, everyday researchers, engineers and clinician scientists worldwide are reporting newer industrially and clinically relevant applications of next-generation biomaterials, iPSCs and adult stem cells. In fact, in the last 5-10 years, the field of iPSCs has witnessed a significant growth in terms of disease modeling, drug development and cell-based therapies. One of the strengths of iPSC-based cell therapies is that these cells are able to differentiate into different types of somatic cells and cover the loss of dead cells after transplantation to the injured organ in the recipient. More recently, iPSC and adult stem cell derived exosomes are also reported to hold potential in initiating the repair process in the host tissue. However there have been several challenges reported in taking iPSC-based therapies toward clinical applications. Some of these challenges are, differentiation potential, immature nature of iPSC derived somatic cells, immunogenicity after transplantation, and teratoma formation. Interestingly biomaterials-based strategies have been able to overcome some of these challenges. However, in order to develop clinically relevant biomaterial-based strategies to mitigate challenges associated with clinical translation of stem cell therapies, it is very important to improve synthesis and characterization strategies to produce need-based and tailored biomaterials. Furthermore, it is very critical to understand how biomaterials work and interact with cells and tissues in our body. Based on these facts, the talks and presentations in this symposium from experts in the field will focus on challenges involved in stem cell reprogramming, differentiation, stem cell derived exosomes-based therapies. The symposium will also cover rational design, synthesis of next-generation biomaterials and application in different biological fields such as regenerative medicine, immunology and cell-based therapies.

  • Session Topic
    Enabling Technology
    Session Title
    S11-F_Tumor engineering with biomaterials
    Date & Time
    2022-10-08 10:30~12:30
    Room
    Room 401
    Organizer
    Eliza Fong (National University of Singapore, Singapore)
    Chair
    Jennifer Young (National University of Singapore, Singapore)
    Giulia Adriani (Agency for Science, Technology and Research (A*STAR), Singapore)
    Keynote
    Kris Kilian (UNSW Sydney, Australia)
    Speaker
    Eliza Fong (National University of Singapore, Singapore)
    Maxine Lam (Institute of Molecular and Cell Biology A-STAR, Singapore)
    Giulia Adriani (Agency for Science, Technology and Research (A*STAR), Singapore)
    JongHyeuk Han (Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Korea, Republic of)
    Jiranuwat Sapudom (Laboratory for Immuno Bioengineering Research and Applications, Division of Engineering, New York University Abu Dhabi, Abu Dhabi, UAE, United Arab Emirates)

    Description

    The purpose of this symposium is to highlight key advances in the field of tumor engineering, specifically with regard to the use of biomaterials engineering and other enabling technologies to develop patient tumor avatars either using the bottom-up or top-down approach. Examples of talks that might be featured include efforts to develop complex cancer organoid-based models to recapitulate the stromal compartment of tumors, models which incorporate the immune contexture of patient tumors for the assessment of immunotherapies, as well as the use of microfluidics to enhance the viability of tumor slice cultures. This symposium will ideally showcase the latest developments in the field of tumor engineering, and serve as a platform to collate ideas and collaborations to advance how we can develop and leverage these models for personalizing cancer medicine and drug development.

Top